Cue Biopharma, Inc. (CUE) vs Niagen Bioscience, Inc. (NAGE)

Cue Biopharma, Inc. and Niagen Bioscience, Inc. are both Biotechnology companies. Cue Biopharma, Inc. and Niagen Bioscience, Inc. are of similar size ($238.6M and $238.2M). Cue Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Cue Biopharma, Inc. grew revenue faster over the last twelve months: 354.4% against 11.0%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −435.8%) and the higher return on invested capital (42.0% vs 0.00%). Across the 17 metrics below, Niagen Bioscience, Inc. leads on 14 and Cue Biopharma, Inc. on 3.